Phio Pharmaceuticals Corp. (PHIO)
NASDAQ: PHIO · Real-Time Price · USD
1.160
-0.010 (-0.85%)
At close: Mar 6, 2026, 4:00 PM EST
1.140
-0.020 (-1.71%)
After-hours: Mar 6, 2026, 7:28 PM EST
Phio Pharmaceuticals Employees
Phio Pharmaceuticals had 5 employees as of December 31, 2024. The number of employees decreased by 4 or -44.44% compared to the previous year.
Employees
5
Change (1Y)
-4
Growth (1Y)
-44.44%
Revenue / Employee
n/a
Profits / Employee
-$1,739,600
Market Cap
12.49M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| BioAtla | 61 |
| CytoMed Therapeutics | 43 |
| BioLineRx | 28 |
| BioCardia | 20 |
| NewcelX | 15 |
| Cellectar Biosciences | 11 |
| Traws Pharma | 7 |
| GT Biopharma | 1 |
PHIO News
- 1 day ago - Phio Pharmaceuticals Reports 2025 Year-End Financial Results and Business Update - Newsfile Corp
- 2 days ago - Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series - Newsfile Corp
- 23 days ago - What's Going On With Tiny Cancer Biotech Phio Pharmaceuticals On Thursday? - Benzinga
- 24 days ago - Cancer Biotech Phio Pharmaceuticals Stock Surges As Trial Shows Tumor Clearance At Highest Dose In Skin Cancer Patients - Benzinga
- 25 days ago - Phio Announces Safety Monitoring Committee's (SMC) Positive Wrap-up on Lead Clinical Candidate PH-762 in Skin Cancer Trial - Newsfile Corp
- 5 weeks ago - Phio Pharmaceuticals Announces Participation in Third Annual DealFlow Discovery Conference - Newsfile Corp
- 6 weeks ago - Phio Pharmaceuticals Announces Key Tumor Response Data from all Cohorts in Intratumoral PH-762 Dose Escalation Cutaneous Carcinoma Trial - Newsfile Corp
- 7 weeks ago - Phio Pharmaceuticals Announces Participation in the Sidoti Micro-Cap Virtual Investor Conference January 21-22, 2026 - Newsfile Corp